Research from the Tokyo University of Science has revealed that polyamines, widely regarded as anti-aging compounds, may also contribute to cancer growth. This study, published in the Journal of Biological Chemistry, highlights the paradox of these natural molecules, which are essential for cellular functions yet linked to the aggressive proliferation of tumors.
Polyamines, including spermidine, are found in every living cell and play a crucial role in cell growth and specialization. Recently, they have gained attention for their potential benefits in supporting healthy aging through a process known as autophagy, which helps clear damaged cellular components. This beneficial process is largely mediated by a protein called eukaryotic translation initiation factor 5A (eIF5A1). However, elevated levels of polyamines have been consistently observed in various cancer types, raising questions about their dual role in cellular health and tumor development.
A Complex Relationship with Cancer Metabolism
Despite the recognition of a link between polyamines and cancer, the specific mechanisms driving tumor progression remained largely unexplored. Cancer cells often undergo metabolic changes, relying heavily on aerobic glycolysis for rapid energy production. The role of polyamines in this metabolic shift had not been fully understood until now.
A research team led by Associate Professor Kyohei Higashi conducted a comprehensive study using advanced molecular and proteomic techniques. Their analysis focused on human cancer cell lines to determine how polyamines influence protein production and metabolism. By manipulating polyamine levels with specific drugs, the researchers were able to observe their direct impact on cancer cells. The study analyzed over 6,700 proteins, revealing that polyamines primarily enhance glycolysis rather than mitochondrial respiration, which is more closely associated with healthy aging.
Insights into eIF5A Proteins
The research also provided significant insights into the roles of eIF5A1 and its closely related counterpart, eIF5A2. While eIF5A1 promotes normal cellular maintenance and energy production, eIF5A2 appears to facilitate cancer cell proliferation. “The biological activity of polyamines via eIF5A differs between normal and cancer tissues,” explained Dr. Higashi. In normal cells, eIF5A1, activated by polyamines, enhances mitochondrial function via autophagy. Conversely, in cancer tissues, eIF5A2, whose synthesis is promoted by polyamines, regulates gene expression to support cancer growth.
Further experiments revealed that polyamines elevate levels of eIF5A2 by disrupting a regulatory mechanism involving a small RNA molecule called miR-6514-5p, which normally restricts eIF5A2 production. This disruption allows for increased levels of eIF5A2, which controls a distinct group of proteins compared to eIF5A1, reinforcing their separate functions within cells.
The implications of this research are profound. The findings suggest that the context in which polyamines operate is crucial. While they may confer anti-aging benefits in healthy tissues through eIF5A1, they can also promote tumor growth in cancerous tissues via eIF5A2. This dual behavior complicates the interpretation of polyamines in medical research and highlights the need for caution in their therapeutic application.
The study identifies eIF5A2 as a potential target for cancer treatment. “Our findings reveal an important role for eIF5A2, regulated by polyamines and miR-6514-5p, in cancer cell proliferation,” noted Dr. Higashi. Targeting eIF5A2 specifically could slow the progression of cancer while preserving the positive effects associated with eIF5A1 on healthy aging.
This research, supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, the Hamaguchi Foundation for the Advancement of Biochemistry, and an Extramural Collaborative Research Grant from the Cancer Research Institute at Kanazawa University, marks a significant step in understanding the complex roles of polyamines. Future studies may lead to strategies that harness their benefits for healthy aging while mitigating their cancer-promoting potential.
